Acceptability and feasibility of point-of-care CD4 testing on HIV continuum of care in low and middle income countries

A systematic review

Minh D. Pham, Paul A. Agius, Lorena Romero, Peter McGlynn, David Anderson, Suzanne M. Crowe, Stanley Luchters

Research output: Contribution to journalReview ArticleResearchpeer-review

12 Citations (Scopus)

Abstract

Background: CD4 testing is, and will remain an important part of HIV treatment and care in low and middle income countries (LMICs). We report the findings of a systematic review assessing acceptability and feasibility of POC CD4 testing in field settings. Methods: Electronic databases were searched for studies published in English between 2005 and 2015 that describe POC CD4 platforms. Studies conducted in LMICs and under field conditions outside a laboratory environment were eligible. Qualitative and descriptive data analysis was used to present the findings. Results: Twelve studies were included, 11 of which were conducted in sub-Saharan countries and used one POC CD4 test (The Alere Pima CD4). Patients reported positively regarding the implementation of POC CD4 testing at primary health care and community level with ≥90 % of patients accepting the test across various study settings. Health service providers expressed preference toward POC CD4 testing as it is easy-to-use, efficient and satisfied patients' needs to a greater extent as compared to conventional methods. However, operational challenges including preference toward venous blood rather than finger-prick sampling, frequent device failures and operator errors, quality of training for test operators and supervisors, and increased staff workload were also identified. Conclusions: POC CD4 testing seems acceptable and feasible in LIMCs under field conditions. Further studies using different POC CD4 tests available on the market are required to provide critical data to support countries in selection and implementation of appropriate POC CD4 technologies.

Original languageEnglish
Article number343
JournalBMC Health Services Research
Volume16
Issue number1
DOIs
Publication statusPublished - 2 Aug 2016

Keywords

  • acceptability
  • CD4
  • feasibility
  • Pima
  • Point-of-care testing
  • systematic review

Cite this

@article{d71de6607c3344a688a228c4b6564f9b,
title = "Acceptability and feasibility of point-of-care CD4 testing on HIV continuum of care in low and middle income countries: A systematic review",
abstract = "Background: CD4 testing is, and will remain an important part of HIV treatment and care in low and middle income countries (LMICs). We report the findings of a systematic review assessing acceptability and feasibility of POC CD4 testing in field settings. Methods: Electronic databases were searched for studies published in English between 2005 and 2015 that describe POC CD4 platforms. Studies conducted in LMICs and under field conditions outside a laboratory environment were eligible. Qualitative and descriptive data analysis was used to present the findings. Results: Twelve studies were included, 11 of which were conducted in sub-Saharan countries and used one POC CD4 test (The Alere Pima CD4). Patients reported positively regarding the implementation of POC CD4 testing at primary health care and community level with ≥90 {\%} of patients accepting the test across various study settings. Health service providers expressed preference toward POC CD4 testing as it is easy-to-use, efficient and satisfied patients' needs to a greater extent as compared to conventional methods. However, operational challenges including preference toward venous blood rather than finger-prick sampling, frequent device failures and operator errors, quality of training for test operators and supervisors, and increased staff workload were also identified. Conclusions: POC CD4 testing seems acceptable and feasible in LIMCs under field conditions. Further studies using different POC CD4 tests available on the market are required to provide critical data to support countries in selection and implementation of appropriate POC CD4 technologies.",
keywords = "acceptability, CD4, feasibility, Pima, Point-of-care testing, systematic review",
author = "Pham, {Minh D.} and Agius, {Paul A.} and Lorena Romero and Peter McGlynn and David Anderson and Crowe, {Suzanne M.} and Stanley Luchters",
year = "2016",
month = "8",
day = "2",
doi = "10.1186/s12913-016-1588-y",
language = "English",
volume = "16",
journal = "BMC Health Services Research",
issn = "1472-6963",
publisher = "Springer-Verlag London Ltd.",
number = "1",

}

Acceptability and feasibility of point-of-care CD4 testing on HIV continuum of care in low and middle income countries : A systematic review. / Pham, Minh D.; Agius, Paul A.; Romero, Lorena; McGlynn, Peter; Anderson, David; Crowe, Suzanne M.; Luchters, Stanley.

In: BMC Health Services Research, Vol. 16, No. 1, 343, 02.08.2016.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Acceptability and feasibility of point-of-care CD4 testing on HIV continuum of care in low and middle income countries

T2 - A systematic review

AU - Pham, Minh D.

AU - Agius, Paul A.

AU - Romero, Lorena

AU - McGlynn, Peter

AU - Anderson, David

AU - Crowe, Suzanne M.

AU - Luchters, Stanley

PY - 2016/8/2

Y1 - 2016/8/2

N2 - Background: CD4 testing is, and will remain an important part of HIV treatment and care in low and middle income countries (LMICs). We report the findings of a systematic review assessing acceptability and feasibility of POC CD4 testing in field settings. Methods: Electronic databases were searched for studies published in English between 2005 and 2015 that describe POC CD4 platforms. Studies conducted in LMICs and under field conditions outside a laboratory environment were eligible. Qualitative and descriptive data analysis was used to present the findings. Results: Twelve studies were included, 11 of which were conducted in sub-Saharan countries and used one POC CD4 test (The Alere Pima CD4). Patients reported positively regarding the implementation of POC CD4 testing at primary health care and community level with ≥90 % of patients accepting the test across various study settings. Health service providers expressed preference toward POC CD4 testing as it is easy-to-use, efficient and satisfied patients' needs to a greater extent as compared to conventional methods. However, operational challenges including preference toward venous blood rather than finger-prick sampling, frequent device failures and operator errors, quality of training for test operators and supervisors, and increased staff workload were also identified. Conclusions: POC CD4 testing seems acceptable and feasible in LIMCs under field conditions. Further studies using different POC CD4 tests available on the market are required to provide critical data to support countries in selection and implementation of appropriate POC CD4 technologies.

AB - Background: CD4 testing is, and will remain an important part of HIV treatment and care in low and middle income countries (LMICs). We report the findings of a systematic review assessing acceptability and feasibility of POC CD4 testing in field settings. Methods: Electronic databases were searched for studies published in English between 2005 and 2015 that describe POC CD4 platforms. Studies conducted in LMICs and under field conditions outside a laboratory environment were eligible. Qualitative and descriptive data analysis was used to present the findings. Results: Twelve studies were included, 11 of which were conducted in sub-Saharan countries and used one POC CD4 test (The Alere Pima CD4). Patients reported positively regarding the implementation of POC CD4 testing at primary health care and community level with ≥90 % of patients accepting the test across various study settings. Health service providers expressed preference toward POC CD4 testing as it is easy-to-use, efficient and satisfied patients' needs to a greater extent as compared to conventional methods. However, operational challenges including preference toward venous blood rather than finger-prick sampling, frequent device failures and operator errors, quality of training for test operators and supervisors, and increased staff workload were also identified. Conclusions: POC CD4 testing seems acceptable and feasible in LIMCs under field conditions. Further studies using different POC CD4 tests available on the market are required to provide critical data to support countries in selection and implementation of appropriate POC CD4 technologies.

KW - acceptability

KW - CD4

KW - feasibility

KW - Pima

KW - Point-of-care testing

KW - systematic review

UR - http://www.scopus.com/inward/record.url?scp=84979992151&partnerID=8YFLogxK

U2 - 10.1186/s12913-016-1588-y

DO - 10.1186/s12913-016-1588-y

M3 - Review Article

VL - 16

JO - BMC Health Services Research

JF - BMC Health Services Research

SN - 1472-6963

IS - 1

M1 - 343

ER -